Epi-On Corneal Crosslinking for Keratoconus

Completed · Phase 4

Conditions studied: Keratoconus, Keratoconus, Unstable

In brief

Epithelium-On Corneal Crosslinking for Keratoconus.

Key facts

Study ID

NCT03245853

Run by

Comprehensive EyeCare of Central Ohio

People needed

20

Starts

2017-07-18

Expected to finish

2019-09-30

Last updated by the study team

2020-01-28

Who can join

Age: 14 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 12 to 40 years of age, having a diagnosis of keratoconus, signed written informed consent, willingness and ability to comply with schedule for follow-up visits

You may not qualify if…

• Previous ocular condition (other than refractive error) in the eye(s) to be treated that may predispose the eye for future complications (herpes simplex/zoster, recurrent corneal erosion syndrome, corneal melt, corneal dystrophy, etc.) Pregnancy, intent to become pregnant, or lactation during study. Corneal pachymetry <350 microns at the thinnest point measured by Pentacam in the eye(s) to be treated.
• Nystagmus or any other condition that would prevent steady gaze. Other systemic condition that in the investigator's opinion would not allow the patient to be a good candidate for the study.

Where it is running

• Comprehensive EyeCare of Central Ohio — Westerville, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.